English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The Opinion of Experts and Stakeholder on Introduction of Orphan or Anticancer Drugs Funding Program Sujin Kim, Seungyeon Jung, and Dong-Sook Kim* Department of Research, Health Insurance Review & Assessment Service, Gangwon-do 26467, Republic of Korea Korea Institute for Pharmaceutical Policy Affairs, Seoul 06708, Republic of Korea (Received July 18, 2020 · Revised September 7, 2020 · Accepted September 8, 2020)